AI BIOTECHNOLOGY LLC enters ONKURE THERAPEUTICS, INC. with 4M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/8/2026ACC: 0001193125-26-146027
10% Owner
Since Mar 2026
4M
Baseline shares
100% direct
4M
Direct ownership
1 position
5.64M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Class A Common Stock
DirectShares owned4M
Total
4M direct4M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 4M | Direct |
| Total | 4M | 4M direct |
Derivative Holdings1
Warrant (right to buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
5.64M
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
5.64M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Class A Common Stock | 0.0001 | — | — | 5.64M | N/A |
| Total | 5.64M | 0.00 | ||||